Powerful Y-90 radiation embedded within each glass microsphere
- Arrives in a custom-sealed source vial with an easy and safe set-up
- Administration takes less than five minutes
- Minimizes residual and no concern for stasis or reflux
Precision-manufactured glass microspheres are the most powerful radiation therapy on the market.
And TheraSphere is the only FDA-approved Y-90 treatment for HCC.
TheraSphere treatment entails precisely formulated glass microspheres infused with high-dose Y-90, delivered with targeted accuracy into hepatocellular carcinoma (HCC) tumors to improve tumor* response and provide longer overall patient survival. ³, ⁴
They’re fighting for quality of life. TheraSphere is uniquely able to help you strike first on both fronts.
*Refers to HCC or associated tumors
TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd., a wholly owned subsidiary of Boston Scientific Corporation.